Show simple item record

dc.contributor.authorDommett, RM
dc.contributor.authorRedaniel, MT
dc.contributor.authorStevens, MC
dc.contributor.authorHamilton, W
dc.contributor.authorMartin, RM
dc.date.accessioned2016-06-30T14:00:44Z
dc.date.issued2012-01-12
dc.description.abstractBACKGROUND: This study investigated the risk of cancer in children with alert symptoms identified in current UK guidance, or with increased consultation frequency in primary care. METHODS: A population-based, nested case-control study used data from the General Practice Research Database. In all, 1267 children age 0-14 years diagnosed with childhood cancer were matched to 15,318 controls. Likelihood ratios and positive predictive values (PPVs) were calculated to assess risk. RESULTS: Alert symptoms recorded in the 12 and 3 months before diagnosis were present in 33.7% and 27.0% of cases vs 5.4% and 1.4% of controls, respectively. The PPV of having cancer for any alert symptom in the 3 months before diagnosis was 0.55 per 1000 children. Cases consulted more frequently particularly in the 3 months before diagnosis (86% cases vs 41% controls). Of these, 36% of cases and 9% of controls had consulted 4 times or more. The PPV for cancer in a child consulting 4 times or more in 3 months was 0.13 per 1000 children. CONCLUSION: Alert symptoms and frequent consultations are associated with childhood cancer. However, individual symptoms and consultation patterns have very low PPVs for cancer in primary care (e.g., of 10,000 children with a recorded alert symptom, approximately 6 would be diagnosed with cancer within 3 months).en_GB
dc.description.sponsorshipRMD is funded by the National Institute for Health Research (NIHR). WH was part funded by a NIHR postdoctoral fellowship. This study is based on data from the Full Feature General Practice Research Database (GPRD) obtained under licence from the UK Medicines and Healthcare Products Regulatory Agency (MHRA). However, the interpretation and conclusions contained in this study are those of the author/s alone. Access to the GPRD was funded through the Medical Research Council (MRC) licence agreement with the UK Medicines and Healthcare Products Regulatory Agency.en_GB
dc.identifier.citationVol. 106, pp. 982 - 987en_GB
dc.identifier.doi10.1038/bjc.2011.600
dc.identifier.otherbjc2011600
dc.identifier.urihttp://hdl.handle.net/10871/22339
dc.language.isoenen_GB
dc.publisherCancer Research UKen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/22240793en_GB
dc.relation.urlhttp://www.nature.com/bjc/journal/v106/n5/full/bjc2011600a.htmlen_GB
dc.rightsThis is the final version of the article. Available from Cancer Research UK via the DOI in this record.en_GB
dc.subjectAdolescenten_GB
dc.subjectAge Factorsen_GB
dc.subjectCase-Control Studiesen_GB
dc.subjectChilden_GB
dc.subjectChild, Preschoolen_GB
dc.subjectFamily Practiceen_GB
dc.subjectFemaleen_GB
dc.subjectGreat Britainen_GB
dc.subjectHumansen_GB
dc.subjectInfanten_GB
dc.subjectMaleen_GB
dc.subjectNeoplasmsen_GB
dc.subjectPopulation Surveillanceen_GB
dc.subjectPrimary Health Careen_GB
dc.subjectRisken_GB
dc.titleFeatures of childhood cancer in primary care: a population-based nested case-control study.en_GB
dc.typeArticleen_GB
dc.date.available2016-06-30T14:00:44Z
dc.identifier.issn0007-0920
exeter.place-of-publicationEnglanden_GB
dc.descriptionPublisheden_GB
dc.descriptionJournal Articleen_GB
dc.descriptionResearch Support, Non-U.S. Gov'ten_GB
dc.identifier.eissn1532-1827
dc.identifier.journalBritish Journal of Canceren_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record